188030-43-5 Usage
General Description
N-(tert-butoxycarbonyl)-3,3,3-trifluoroalanine is a chemical compound that belongs to the class of aliphatic and cyclic amino acids and derivatives. It is a derivative of alanine with a tert-butoxycarbonyl (Boc) protecting group attached to the nitrogen atom of the amino acid. The presence of the trifluoromethyl group on the alpha carbon makes it highly fluorinated and potentially useful for medicinal chemistry and drug development. N-(TERT-BUTOXYCARBONYL)-3,3,3-TRIFLUOROALANINE can be used as a building block in the synthesis of peptides and other pharmaceutical agents, and its unique properties make it valuable in the development of novel drug candidates. It is important to handle this compound with care, following proper safety protocols and procedures, due to its potentially hazardous nature.
Check Digit Verification of cas no
The CAS Registry Mumber 188030-43-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,0,3 and 0 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 188030-43:
(8*1)+(7*8)+(6*8)+(5*0)+(4*3)+(3*0)+(2*4)+(1*3)=135
135 % 10 = 5
So 188030-43-5 is a valid CAS Registry Number.
188030-43-5Relevant articles and documents
SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE
-
Page/Page column 754, (2016/04/10)
Compounds having a structure of Formula (IX) or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b, Q1----Q2, R6, R7, A, B, W, x, and y are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.
Pyrrolopyrazine Kinase Inhibitors
-
Page/Page column 70, (2011/10/10)
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables n, p, q, Q, X, X′ and Y are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
